Project Grant R01TR003844
Award Date 8/9/21
Completion Date 7/31/25
Dollars Obligated $3.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded The Johns Hopkins University a $1,031,754 Project Grant on September 2, 2025, for a five-year performance period concluding August 31, 2030. The award supports preclinical and translational research to advance kidney xenotransplantation (KXTX)—the transplantation of genetically modified pig organs into nonhuman primates and...
- Summary Oregon Health & Science University (OHSU) received a $1,329,538 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, with a completion date of April 30, 2030. The project focuses on developing genetically enhanced allogeneic hepatocytes for transplantation without requiring immunosuppression. OHSU will conduct three...
- Summary of Federal Cooperative Agreement Award New York University School of Medicine received a $2.86M Cooperative Agreement from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025 through May 31, 2030. The award funds research applying genomics and omics (multi-omic analyses) to advance pig-to-human xenotransplantation outcomes. The primary deliverables include development of...
- Federal Project Grant Award Summary Renovate Biosciences Inc. received a $584,232 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 25, 2025, with completion targeted for August 31, 2026. The award supports the BLIPS (Biocompatible Liver in Pigs) project, which aims to develop xenotransplantation technology using pigs as...
- This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $1,800,000 to Missouri University of Science & Technology to develop an artificial intelligence decision support system for kidney transplant healthcare. The goal is to reduce kidney discard rates by at least 10% by embedding preferences and fairness considerations into AI models used to match donor kidneys with transplant centers. Two subawards totaling $XXX,XXX are provided to Saint...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $444,125 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The award supports investigator-initiated research focused on addressing early xenograft rejection in xenotransplantation—specifically, the simultaneous targeting of immunoglobulin G (IgG)...
- This $667,697 Project Grant awarded March 1, 2025, by the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research to identify and disseminate bioethical concerns related to bionic and robotic prostheses development and clinical translation. The University of North Texas Health Science Center at Fort Worth will conduct a two-year study (through February 28,...
- Federal Project Grant Summary New York University School of Medicine received a $762,747 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 22, 2025 through May 31, 2030. The grant funds research to develop engagement protocols for donor family members and healthcare staff involved in research studies utilizing recently deceased humans maintained physiologically following declaration of...
- Summary Johns Hopkins University's Institute for Clinical and Translational Research (ICTR) received $1,095,342 in funding from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, awarded September 15, 2025, with performance extending through August 31, 2030. This postdoctoral training grant (T32) delivers an integrated set of training opportunities designed to develop the next generation of clinical and translational science researchers. The program provides core...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,074,434.37 Project Grant to the Massachusetts General Hospital under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 17, 2021 with a completion date of July 12, 2021. The grant funding supports research to develop protocols to induce tolerance in non-human primate heart allograft recipients without chronic immunosuppression. The awardee will test approaches to either...